Inventor · Zumikon, CH

Roger Nitsch

32Patents
9h-index
46Co-inventors
75Inventor score

Filing activity: Apr 15, 1994 → May 28, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US8940272B2 Human anti-tau antibodies Physics 27 Active
US8906367B2 Method of providing disease-specific binding molecules and targets Chemistry; Metallurgy 18 Active
US8940276B2 Human anti-alpha-synuclein antibodies Physics 17 Active
US5631168A Antemortem diagnostic test for Alzheimer's disease Physics 17 Expired
US5545566A Antemortem diagnostic test for alzheimer's disease Physics 12 Expired
US9670272B2 Method of providing disease-specific binding molecules and targets Physics 11 Active
US9828420B2 Method of providing disease-specific binding molecules and targets Physics 11 Active
US9605059B2 Human anti-tau antibodies Physics 10 Active
US5962463A Methods of stimulating non-amyloidogenic processing of the amyloid precursor protein Physics 9 Expired
US9580493B2 Anti-α synuclein binding molecules Physics 8 Active
US10131708B2 Methods of treating Alzheimer's disease Physics 8 Active
US6329155A Methods of identifying agents which regulate release of amyloid precursor protein Emerging Cross-Sectional Technologies 7 Expired
US9896504B2 Human anti-alpha-synuclein antibodies Physics 6 Active
US10202445B2 Method of providing disease-specific binding molecules and targets Physics 6 Active
US6573276B2 Muscarinic M1 agonist as an inhibitor of beta-amyloid (A&bgr;40 and A&bgr;42)-synthesis Human Necessities 5 Expired
US8022268B2 Transgenic animal model for alzheimer's disease Chemistry; Metallurgy 5 Active
US10259866B2 TDP-43 specific binding molecules Physics 4 Active
US10874725B2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Emerging Cross-Sectional Technologies 3 Active
US9283271B2 Human anti-SOD1 antibodies Physics 3 Active
US9587014B2 TDP-43 specific binding molecules Physics 3 Active
US9370531B2 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders Emerging Cross-Sectional Technologies 3 Active
US10301381B2 Anti-alpha synuclein binding molecules Physics 2 Active
US9975947B2 Anti-alpha synuclein binding molecules Physics 2 Active
US10344097B2 Human anti-SOD1 antibodies Physics 1 Active
US8323647B2 Humanized antibodies against the β-amyloid peptide Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.